For men with intermediate-risk prostate cancer, a trial reveals improvements in several clinical outcomes.

Published Date: 03 May 2023

The primary endpoint of the phase 3 NRG Oncology RTOG 0815 clinical study, which compared dose-escalated radiotherapy (RT) alone to dose-escalated RT with short-term androgen deprivation (STAD), was not met.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers find distinct cell receptors with the potential for new treatments.

2.

Breast cancer patients' arms swell less after an effective lymph node transfer.

3.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

4.

Too Many Chest CTs for Incidental Lung Nodules?

5.

Global warming could be driving up women's cancer risk, find researchers


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot